Buy LogicBio Therapeutics Inc Stock | LOGC Stock Price & Latest News | Public
LOGC

LogicBio Therapeutics Inc

$0.00 (0.00%)Today
    Small Market Cap

    About LOGC

    LogicBio Therapeutics, Inc. is a genome editing company, which engages in developing medicines to treat rare diseases in patients with significant unmet medical need. It focuses on the commercialization of specific genome editing and integration of the therapeutic trans...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.14
    -0.27
    -0.41
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.33

    Actual EPS
    Q4 2020

    Stats

    Market Cap$156,1M
    Volume1,46k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$11.60
    1 Year Low$3.05
    Open$6.30
    High$6.61
    Low$6.30

    Buy any stock with any amount of money.

    Download the App
    Download the app